Oncologists Accepting Medicare in Boston, MA
182 verified oncologists in Boston, Massachusetts accept Medicare. Profiles cover focus areas including Genitourinary Oncology, Medical Oncology, and Head & Neck Oncology. Common hospital affiliations include Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Newton-wellesley Hospital.
Ursula Matulonis, MD
Professor of Medicine, Harvard Medical School; Chief and Director, Division of Gynecologic Oncology, Dana-Farber Cancer Institute
Oncology
Robert Haddad, MD
Chief, Division of Head and Neck Oncology; McGraw Chair in Head and Neck Oncology; Professor of Medicine, Harvard Medical School
Oncology
Patrick Ott, MD
Professor of Medicine, Harvard Medical School; Clinical Director, Melanoma Disease Center; Director, Clinical Sciences, Center for Immuno-Oncology; Senior Physician
Oncology
Kenneth Anderson, MD
Kraft Family Professor of Medicine, Harvard Medical School; Director, LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute
Oncology
Mary-Ellen Taplin, MD
Professor of Medicine, Harvard Medical School; Institute Physician and Director of Clinical Research, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
Oncology
Muneeb Ahmed, M.D.
Miriam H. Stoneman Professor of Radiology, Harvard Medical School; Chief, Division of Vascular and Interventional Radiology, Beth Israel Deaconess Medical Center; Chair of the Imaging Department, Dana-Farber Cancer Institute
Oncology
Vincent Ho, MD
Professor of Medicine, Harvard Medical School; Director of Clinical Operations, Stem Cell Transplantation, Dana-Farber Cancer Institute
Oncology
Susana Campos, MD MPH
Assistant Professor, Medicine, Brigham and Women's Hospital, Harvard Medical School
Oncology
Suzanne George, MD
Chief, Division of Sarcoma; Clinical Research Director, Sarcoma Center; Associate Professor of Medicine, Harvard Medical School
Oncology
Himisha Beltran, MD
Associate Professor of Medicine, Lank Center for Genitourinary Oncology and Division of Molecular and Cellular Oncology; Director of Translational Research, Medical Oncology
Oncology
Joseph Antin, MD
Chairman of the Steering Committee of the BMT Clinical Trial Network.; Chief, Stem Cell Transplantation, Emeritus
Oncology
Jennifer Chan, MD
Associate Professor of Medicine, Harvard Medical School; Clinical Director, Gastrointestinal Cancer Center; Director, Program in Carcinoid and Neuroendocrine Tumors, Dana-Farber Cancer Institute
Oncology
Geoffrey Shapiro, MD PHD
Senior Vice President, Developmental Therapeutics; Clinical Director, Center for DNA Damage and Repair; Professor of Medicine, Harvard Medical School; Institute Physician, Dana-Farber Cancer Institute
Oncology
Robert Soiffer, MD
Chief of the Division of Hematologic Malignancies; Codirector of the Adult Stem Cell Transplantation Program; Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic Oncology, Harvard Medical School
Oncology
Elizabeth Mittendorf, M.D.
Professor of Surgery at Harvard Medical School; Robert and Karen Hale Endowed Chair in Surgical Oncology at Brigham and Women's Hospital; Chief of Division of Breast Surgery at Beth Israel Deaconess Medical Center; Co-Leader of the Parker Institute for Cancer Immunotherapy at Dana-Farber Cancer Institute; Co-Leader of the Breast Program for the Dana-Farber/Harvard Cancer Center; President-elect of the American Society of Clinical Oncology (ASCO) 2026-2027
Oncology
Matthew Smith, MD PHD
Professor of Medicine, Harvard Medical School; Director, Genitourinary Oncology Program, Massachusetts General Hospital Cancer Center
Oncology
Harold Burstein, MD PHD
Director of Academic Partnerships; Director of Breast Cancer Education
Oncology
Arnold Freedman, MD
Professor of Medicine at Harvard Medical School, a member of Dana-Farber Cancer Institute's Department of Medical Oncology, and an attending physician at Brigh; Professor of Medicine, Harvard Medical School
Oncology
Janet Abrahm, MD
Professor of Medicine, Harvard Medical School; Chief Resident
Oncology
Peter Orio, D.O.
Chair of the Department of Radiation Oncology at Dana-Farber Cancer Institute. For the past ten years, he served as the Vice Chair of Network Operations fo
Oncology